TetraLogic Announces the Opening of an IND for SHAPE Gel in Alopecia Areata
02 nov. 2015 07h00 HE
|
TetraLogic Pharmaceuticals
MALVERN, Pa., Nov. 2, 2015 (GLOBE NEWSWIRE) -- TetraLogic Pharmaceuticals Corporation (Nasdaq:TLOG) today announced that it has an open U.S. Investigational New Drug application in support of a Phase...
TetraLogic Reports Second Quarter Financial Results and Provides Clinical Programs Update
05 août 2015 16h01 HE
|
TetraLogic Pharmaceuticals
MALVERN, Pa., Aug. 5, 2015 (GLOBE NEWSWIRE) -- TetraLogic Pharmaceuticals Corporation (Nasdaq:TLOG), a clinical-stage biopharmaceutical company focused on discovering and developing novel small...
TetraLogic Announces Update on MDS Clinical Program
30 juin 2015 16h01 HE
|
TetraLogic Pharmaceuticals
MALVERN, Pa., June 30, 2015 (GLOBE NEWSWIRE) -- TetraLogic Pharmaceuticals Corporation (NASDAQ:TLOG), a clinical-stage biopharmaceutical company focused on discovering and developing novel small...